-
公开(公告)号:US12053627B2
公开(公告)日:2024-08-06
申请号:US17199082
申请日:2021-03-11
申请人: Medtronic, Inc.
发明人: Scott R. Stanslaski , Timothy R. Abraham , Thomas Adamski , Timothy J. Denison , Robert S. Raike , Christopher L. Pulliam
CPC分类号: A61N1/0534 , A61B5/24 , A61B5/374 , A61B5/4836 , A61B5/4848 , A61B5/686 , A61B5/6868 , A61N1/36064 , A61N1/36067 , A61N1/36071 , A61N1/36082 , A61N1/36132 , A61N1/36135 , A61N1/36139 , A61N1/37247 , A61B5/0002 , A61N1/0476 , A61N1/36014 , A61N1/36096
摘要: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first response of a first sensed signal of the patient to the electrical stimulation therapy and a second response of a second sensed signal of the patient to the electrical stimulation therapy. Based on the first response and the second response for controlling the electrical stimulation therapy, the medical system selects one of the first sensed signal and the second sensed signal of the patient. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
-
公开(公告)号:US11672969B2
公开(公告)日:2023-06-13
申请号:US16947954
申请日:2020-08-25
申请人: Medtronic, Inc.
发明人: Anthony M. Chasensky , Bernard Q. Li , Brad C. Tischendorf , Chris J. Paidosh , Christian S. Nielsen , Craig L. Schmidt , David A. Dinsmoor , Duane L. Bourget , Eric H. Bonde , Erik R. Scott , Forrest C M Pape , Gabriela C. Molnar , Gordon O. Munns , Joel A. Anderson , John E. Kast , Joseph J. Viavattine , Markus W. Reiterer , Michael J. Ebert , Phillip C. Falkner , Prabhakar A. Tamirisa , Randy S. Roles , Reginald D. Robinson , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Thomas P. Miltich , Timothy J. Denison , Todd V. Smith , Xuan K. Wei
CPC分类号: A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/3605 , A61N1/36007 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
摘要: A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.
-
3.
公开(公告)号:US11648398B2
公开(公告)日:2023-05-16
申请号:US16774418
申请日:2020-01-28
申请人: Medtronic, Inc.
发明人: Ashutosh Chaturvedi , Siddharth Dani , Timothy J. Denison , William F. Kaemmerer , Shahram Malekkhosravi , Eric J. Panken , Brandon Zingsheim
IPC分类号: G16H50/50 , G16H20/40 , G16H20/30 , A61B5/291 , G16H50/30 , A61B5/24 , A61N1/36 , A61N1/372 , A61B5/00
CPC分类号: A61N1/36128 , A61B5/291 , A61B5/4064 , A61B5/4833 , A61N1/3605 , A61N1/36067 , A61N1/36082 , A61N1/36096 , A61N1/36132 , A61N1/36182 , A61N1/37247 , G16H20/30 , G16H20/40 , G16H50/50 , A61B5/24 , A61B5/4076 , G16H50/30
摘要: In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using an efficacy map comprising a plurality of voxels that are each assigned a value. In some examples, the efficacy map is selected from a plurality of stored efficacy maps based on a patient condition, one or more patient symptoms, or both the patient condition and one or more patient symptoms. In addition, in some examples, voxels of the efficacy map are assigned respective values that are associated with a clinical rating scale.
-
公开(公告)号:US11628302B2
公开(公告)日:2023-04-18
申请号:US17017442
申请日:2020-09-10
申请人: Medtronic, Inc.
发明人: William F. Kaemmerer , Duane L. Bourget , Timothy J. Denison , Eric J. Panken , Scott R. Stanslaski
摘要: A medical device may receive sensor data from sensing sources, and determine confidence levels for sensor data received from each of the plurality of sensing sources. Each of the confidence levels of the sensor data from each of the sensing sources is a measure of accuracy of the sensor data received from respective sensing sources. The medical device may also determine one or more therapy parameter values based on the determined confidence levels, and cause delivery of therapy based on the determined one or more therapy parameter values.
-
公开(公告)号:US11511115B2
公开(公告)日:2022-11-29
申请号:US16110439
申请日:2018-08-23
申请人: Medtronic, Inc.
摘要: Systems and method may be used for interfacing with a patient. Systems may include a plurality of electrodes in electrical communication with a processor. The processor may be configured to receive sense signals from electrodes and to determine the reliability of the received signal. A test tone signal comprising a test tone frequency may be applied, and the magnitude of the test tone frequency may be analyzed in the received signal. If it is determined that the magnitude of the test tone frequency is below a threshold, the system may take action, such as lowering the gain on an amplifier. Stimulation signals may be applied to the patient at a stimulation frequency simultaneously with one or both of receiving sense signals and providing the test tone signal.
-
公开(公告)号:US20220176128A1
公开(公告)日:2022-06-09
申请号:US17552866
申请日:2021-12-16
申请人: Medtronic, Inc.
发明人: David A. Dinsmoor , Timothy J. Denison , Xin Su
摘要: This disclosure relates to methods, devices, and systems for delivering and adjusting stimulation therapy. In one example, a method comprising delivering, by a stimulation electrode, electrical stimulation as a candidate therapy to a patient according to a set of candidate therapy parameters, the stimulation electrode located in proximity to the dorsal column of a patient; sensing, by a sensing electrode, an electrically evoked compound action potential (eECAP) signal in response to the delivery of the electrical stimulation; and classifying, by a processor, the sensed eECAP signal generated in response to the application of the candidate therapy relative to an eECAP baseline is disclosed.
-
公开(公告)号:US11103172B2
公开(公告)日:2021-08-31
申请号:US14064801
申请日:2013-10-28
申请人: Medtronic, Inc.
摘要: Devices and methods provide for the sensing of physiological signals during stimulation therapy by preventing stimulation waveform artifacts from being passed through to the amplification of the sensed physiological signal. Thus, the amplifiers are not adversely affected by the stimulation waveform and can provide for successful sensing of physiological signals between stimulation waveform pulses. A blanking switch may be used to blank the stimulation waveform artifacts where the blanking switch is operated in a manner synchronized with the stimulation waveform so that conduction in the sensing path is blocked during the stimulation pulse as well as during other troublesome artifacts such as a peak of a recharge pulse. A limiter may be used to limit the amplitude of the sensed signal, and hence the stimulation artifacts, that are passed to the amplifier without any synchronization of the limiter to the stimulation waveform.
-
公开(公告)号:US20210060331A1
公开(公告)日:2021-03-04
申请号:US17097776
申请日:2020-11-13
申请人: Medtronic, Inc.
发明人: Scott R. Stanslaski , Timothy R. Abraham , Thomas Adamski , Timothy J. Denison , Robert S. Raike
摘要: Techniques are disclosed for delivering electrical stimulation therapy to a patient. In one example, a medical system delivers electrical stimulation therapy to a tissue of the patient via electrodes. The medical system determines a first change of a first sensed signal of the patient to movement by the patient and a second change of a second sensed signal of the patient to the movement by the patient. Based on the first change and the second change, the medical system selects one of the first sensed signal and the second sensed signal of the patient for controlling the electrical stimulation therapy. The medical system adjusts a level of at least one parameter of the electrical stimulation therapy based on the selected one of the first sensed signal and the second sensed signal.
-
公开(公告)号:US20200376255A1
公开(公告)日:2020-12-03
申请号:US16947944
申请日:2020-08-25
申请人: Medtronic, Inc.
发明人: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
摘要: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US20200171312A1
公开(公告)日:2020-06-04
申请号:US16782986
申请日:2020-02-05
申请人: Medtronic, Inc.
发明人: David A. Dinsmoor , Timothy J. Denison , Xin Su
摘要: This disclosure relates to methods, devices, and systems for delivering and adjusting stimulation therapy. In one example, a method comprising delivering, by a stimulation electrode, electrical stimulation as a candidate therapy to a patient according to a set of candidate therapy parameters, the stimulation electrode located in proximity to the dorsal column of a patient; sensing, by a sensing electrode, an electrically evoked compound action potential (eECAP) signal in response to the delivery of the electrical stimulation; and classifying, by a processor, the sensed eECAP signal generated in response to the application of the candidate therapy relative to an eECAP baseline is disclosed.
-
-
-
-
-
-
-
-
-